not tagged
seagen,genmab
['seagen']
at #asco22, with , we re presenting interim data from the innovatv 205 trial, which investigated combinations of antibody-drug conjugate therapy and other cancer agents in patients with high unmet need. 
We are a leader in harnessing the power of human antibodies and our purpose is to improve the lives of people with cancer | Disclaimer https://t.co/E8NokG2tvL